Literature DB >> 17768180

An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea.

Vanessa Liévin-Le Moal1, Luis E Sarrazin-Davila, Alain L Servin.   

Abstract

OBJECTIVE: Previous studies have shown that selected strains of Lactobacillus have the capacity to antagonize rotavirus-induced diarrhea. However, only a few reports have documented their efficacy against nonrotavirus diarrhea. This study involved an experimental investigation and a clinical trial of the antisecretory activity of Lactobacillus acidophilus strain LB in the context of nonrotavirus diarrhea.
METHODS: The activity of a culture of L. acidophilus LB or of the lyophilized, heat-killed L. acidophilus LB bacteria plus their spent culture medium was tested in inhibiting the formation of fluid-formed domes in cultured human intestinal Caco-2/TC7 cell monolayers infected with diarrheagenic, diffusely adhering Afa/Dr Escherichia coli C1845 bacteria. A randomized, double-blind, placebo-controlled clinical trial of male or female children who were 10 months of age and presented with nonrotavirus, well-established diarrhea was conducted to evaluate the therapeutic efficacy of a pharmaceutical preparation that contains 10 billion heat-killed L. acidophilus LB plus 160 mg of spent culture medium.
RESULTS: Infection of the cells with C1845 bacteria that were treated with L. acidophilus LB culture or the lyophilized, heat-killed L. acidophilus LB bacteria plus their culture medium produced a dosage-dependent decrease in the number of fluid-formed domes as compared with cells that were infected with untreated C1845 bacteria. The clinical results show that in selected and controlled homogeneous groups of children with well-established, nonrotavirus diarrhea, adding lyophilized, heat-killed L. acidophilus LB bacteria plus their culture medium to a solution of oral rehydration solution shortened by 1 day the recovery time (ie, the time until the first normal stool was passed) as compared with children who received placebo oral rehydration solution.
CONCLUSIONS: Heat-killed L. acidophilus LB plus its culture medium antagonizes the C1845-induced increase in paracellular permeability in intestinal Caco-2/TC7 cells and produces a clinically significant benefit in the management of children with nonrotavirus, well-established diarrhea.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768180     DOI: 10.1542/peds.2006-2930

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

1.  Impairment of swimming motility by antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar Typhimurium within human enterocyte-like cells.

Authors:  Vanessa Liévin-Le Moal; Raymonde Amsellem; Alain L Servin
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

Review 2.  Probiotics for treating acute infectious diarrhoea.

Authors:  Stephen J Allen; Elizabeth G Martinez; Germana V Gregorio; Leonila F Dans
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

Review 3.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

4.  AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.

Authors:  Geoffrey A Preidis; Adam V Weizman; Purna C Kashyap; Rebecca L Morgan
Journal:  Gastroenterology       Date:  2020-06-09       Impact factor: 22.682

Review 5.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea.

Authors:  S Rerksuppaphol; L Rerksuppaphol
Journal:  Ann Trop Paediatr       Date:  2010

7.  Probiotics for treating acute infectious diarrhoea.

Authors:  Shelui Collinson; Andrew Deans; April Padua-Zamora; Germana V Gregorio; Chao Li; Leonila F Dans; Stephen J Allen
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

Review 8.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

Review 9.  Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Authors:  Rodrigo D De Oliveira Carvalho; Fillipe L R do Carmo; Alberto de Oliveira Junior; Philippe Langella; Jean-Marc Chatel; Luis G Bermúdez-Humarán; Vasco Azevedo; Marcela S de Azevedo
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

10.  A meta-analysis of the effects of probiotics and synbiotics in children with acute diarrhea.

Authors:  Bo Yang; Ping Lu; Mei-Xuan Li; Xiao-Ling Cai; Wan-Yuan Xiong; Huai-Jing Hou; Xiao-Qin Ha
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.